What is the interpretation of a patient's dexamethasone suppression test (DST) results with a total cortisol level of 0.9 and a dexamethasone level of 353?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 7, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

DST Results Interpretation: Normal Suppression Confirmed

Your patient's dexamethasone suppression test demonstrates normal cortisol suppression with adequate dexamethasone levels, effectively ruling out Cushing's syndrome and autonomous cortisol secretion. 1, 2

Test Result Analysis

Cortisol Level Assessment

  • Post-DST cortisol of 0.9 μg/dL is well below the diagnostic threshold of 1.8 μg/dL (50 nmol/L) that defines normal suppression 1, 2
  • This result is approximately 50% of the upper limit of normal, indicating robust suppression of the hypothalamic-pituitary-adrenal axis 1
  • Values >5 μg/dL would indicate overt Cushing's syndrome, making your result clearly normal 1, 2

Dexamethasone Level Verification

  • Dexamethasone level of 353 ng/mL (3.53 μg/dL) confirms adequate drug absorption and metabolism 1, 2
  • The minimum threshold for adequate dexamethasone concentration is 1.8 ng/mL (0.018 μg/dL), and your patient's level is nearly 200-fold higher 2
  • This eliminates false-negative results from rapid dexamethasone metabolism, CYP3A4 inducers, or malabsorption 1, 2
  • Measuring dexamethasone levels concomitantly reduces false-positive DST results and confirms test validity 3, 1

Clinical Implications

Diagnostic Conclusions

  • Cushing's syndrome is excluded with high confidence based on appropriate cortisol suppression with verified dexamethasone levels 1, 2
  • The intact negative feedback mechanism of the HPA axis is demonstrated 2
  • If this test was performed for adrenal incidentaloma evaluation, the mass can be classified as non-functioning from a cortisol perspective 1

No Further Testing Required

  • No additional biochemical testing for hypercortisolism is warranted based on this normal result 1, 4
  • Do not pursue invasive testing such as inferior petrosal sinus sampling, as IPSS should never be used to diagnose hypercortisolism 3, 4

Critical Pitfalls Avoided

Test Validity Confirmed

  • The high dexamethasone level excludes common causes of false-positive DST results 1, 2:
    • CYP3A4 inducers (phenytoin, rifampin, carbamazepine) that accelerate dexamethasone metabolism
    • Malabsorption or inadequate dosing
    • Patient non-compliance with medication timing

Factors That Would Require Consideration (Not Applicable Here)

  • Oral contraceptives/estrogen therapy can elevate cortisol-binding globulin, falsely increasing total cortisol, but this would cause elevated post-DST cortisol, not the low value seen here 1, 5
  • Pseudo-Cushing's states (depression, alcoholism, severe obesity) can cause false-positive DST, but your patient's result is clearly negative 3, 1

Exception: Cyclic Cushing's Consideration

Only pursue further evaluation if clinical suspicion remains extremely high despite this normal result 3, 4:

  • Cyclic Cushing's syndrome can produce weeks to months of normal cortisol secretion interspersed with hypercortisolism episodes 4
  • This would require 3-6 months of serial testing (late-night salivary cortisol, 24-hour urinary free cortisol) during symptomatic periods 3, 4
  • Dynamic testing and localization should be preceded by confirmatory testing to document active phase 3
  • This approach is only justified with compelling clinical features of Cushing's syndrome 4

References

Guideline

Cortisol Levels and Diagnostic Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Diagnosing Cushing's Syndrome with Dexamethasone Suppression Test

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Cushing's Syndrome Diagnosis and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

Does Topiramate (topiramate) affect the serum Ante Meridiem (AM) cortisol level or the dexamethasone suppression test?
Must angiotensin-converting enzyme (ACE) inhibitors be discontinued prior to dexamethasone suppression testing?
What does a cortisol level of 1.2 after a dexamethasone (DEX) suppression test indicate?
How is a dexamethasone (corticosteroid) suppression test result interpreted?
What to do if post-dexamethasone (cortisol suppression test) cortisol level is borderline, should I proceed with an 8 mg dexamethasone (cortisol suppression test)?
What is the management and treatment of cystic pulmonary diseases, such as Lymphangioleiomyomatosis (LAM) and Pulmonary Langerhans Cell Histiocytosis (PLCH), in patients with respiratory symptoms and impaired lung function?
What is the most appropriate procedure for a 7-week pregnant patient with a right-sided 4-cm ectopic pregnancy and a left tubal hydrosalpinx, who conceived through in-vitro fertilization (IVF)?
What is the recommended diuretic regimen for patients with impaired renal function undergoing dialysis?
What is the appropriate use and dosage of Zurzuvae (generic name not specified) for a healthy adult postpartum female patient?
Can metronidazole (Flagyl) 2g orally (PO) daily for 7 days be given as 1g twice a day (bid)?
What is the best treatment approach for a patient with a nagging cough and excessive sputum production due to a cold, considering potential underlying conditions such as asthma or Chronic Obstructive Pulmonary Disease (COPD)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.